Effects of Epigenetic Drugs on BRCA1 and CHD5 Expressions in Breast Cancer Cells

WANG Xin-gang,WANG Xiao-feng,LI Fu-nian,HOU Lin,YANG Qi-feng

2011-01-01

Abstract:Objective To investigate effects of epigenetic drugs on expressions of breast cancer susceptibility gene1(BRCA1) and chromodomain helicase DNA-binding protein(CHD5) in breast cancer cells,and explore the proper use of these drugs in breast cancer therapy.Methods MCF-7,T47D and HBL-100 cells were exposed to 5-azacytidine(5-AZA) of 0,0.5,1.0,2.5,5.0 and 10.0 μmol/L for 12,24,48 and 72 h,and trichostatin A(TSA) of 0,0.25,0.5,0.75,1 and 1.5 μmol/L for 6,12,24,48 and 72 h.After treatment,BRCA1 and CHD5 expressions were determined by quantitative RT-PCR,and methylation status of both genes was determined by methylation-specific PCR(MSP).Results 2.5 μmol/L of 5-AZA and 0.5 μmol/L of TSA could improve expressions of BRCA1 and CHD5 in breast cancer cells,while drugs with too high doses,10 μmol/L of AZA and 1 and 1.5 μmol/L of TSA could decrease both gene expressions and were even toxic to normal cells.MSP showed no alterations in methylation status of BRCA1 in either cell line or CHD5 in MCF-7 after treatment,while both agents could reverse methylation status of CHD5 in T47D.Conclusion Epigenetic drugs have a dose-and time-dependent influence on tumor suppressor gene expression,and the present study provides fundamental experimental data for designed epigenetic therapy of breast cancer.